Epilepsy Research
Volume 24, Issue 3 , Pages 127-136 , July 1996

Outcome assessment in epilepsy: available rating scales for adults and methodological issues pertaining to the development of scales for childhood epilepsy

  • Hans A. Carpay

      Affiliations

    • Corresponding Author InformationCorresponding author. Present address: Department of Clinical Neurophysiology, Westeinde Hospital, PO Box 432, 2501 CK Den Haag, The Netherlands. Tel.: +31 (70) 330 2000; fax: +31 (70) 380 9459.
    • ,
  • Willem F.M. Arts

Received 11 October 1995 ,Revised 2 February 1996 ,Accepted 2 February 1996.

References 

  1. In: Quality of life and clinical trials. 4th Ed.. Lancet. 346:1995;p. 1–2
  2. Aldenkamp AP, Alpherts WCJ, Blennow G, et al.  Withdrawal of antiepileptic medication in children — effects on cognitive function: the multicenter Holmfrid study. Neurology. 1993;43:41–50
  3. Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia. 1979;20:729–737
  4. Arts WFM, van Donselaar CA, Geerts AT, Brouwer OF, Peters ACB, Stroink H. The Dutch study of epilepsy in childhood: study on the prognosis of epilepsy in childhood. Epilepsia. 1995;36(Suppl. 3):S28–S29 (Abstract)
  5. Arts WFM, van Donselaar CA, Stroink H, Peters ACB, Brouwer OF. Follow-up of intractable seizures in childhood. Ann. Neurol. 1991;30:115
  6. Austin JK, Austin DR. Family activity, supervision, and child activity in new-onset epilepsy. Epilepsia. 1995;36(Suppl. 3):S170; (Abstract)
  7. Austin JK, Dunn DW, Huster GR. Differences in quality of life ratings among adolescents, parents, and teachers. Epilepsia. 1995;36(Suppl. 3):S190; (Abstract)
  8. Austin JK, Shelton Smith M, Risinger MW, McNelis AM. Childhood epilepsy and asthma: comparison of quality of life. Epilepsia. 1994;35:608–615
  9. Baker GA. Health-related quality-of-life issues: optimizing patient outcomes. Neurology. 1995;45(Suppl. 2):S29–S34
  10. Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res. 1993;16:65–81
  11. Baker GA, Smith DF, Dewey M, Morrow J, Crawford PM, Chadwick DW. The development of a seizure severity scale as an outcome measure in epilepsy. Epilepsy Res. 1991;8:245–251
  12. Beckung E, Uvebrant P. Motor and sensory impairments in children with intractable epilepsy. Epilepsia. 1993;34:924–929
  13. Belle G, Temkin N. Design strategies in the clinical evaluation of new antiepileptic drugs. In:  Pedley TA,  Meldrum BS editor. Recent Advances in Epilepsy. Edinburgh: Churchill Livingstone; 1983;p. 93–110
  14. Berg AT, Hauser WA, Shinnar S. The prognosis of childhoo-onset epilepsy. In: 4th Ed..  Shinnar S,  Amir N,  Branski D editor. Childhood Seizures. Pediatric and Adolescent Medicine. Vol 6:Basel: Karger; 1995;p. 93–99
  15. Blume WT. Uncontrolled epilepsy in children. Epilepsy Res. 1992;9(Suppl. 5):19–24
  16. Brorson LO, Wranne L. Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia. 1987;28:324–330
  17. Carpay JA, Arts WFM, Vermuelen J  Dutch Study Group of Epilepsy in Childhood. The parents' perception of the severity of childhood epilepsy. Epilepsia. 1995;36(Suppl. 3):S171; (Abstract)
  18. Chadwick DW. Standard approach to antiepileptic treatment in the United Kingdom. Epilepsia. 1994;35(Suppl. 4):S3–S10
  19. Commission on antiepileptic drugs of the ILAE . Guidelines for antiepileptic drug trials in children. Epilepsia. 1994;35:94–100
  20. Commission on Classification and Terminology of the ILAE . Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489–501
  21. Committee on drugs . Behavioural and cognitive effects of anticonvulsant therapy. Pediatrics. 1985;76:644–647
  22. Cramer JA. A clinimetric approah to assessing quality of life in epilepsy. Epilepsia. 1993;34(Suppl. 4):S8–S13
  23. Cramer JA, Smith DB, Mattson RH, Delgado-Escueta AV, Collins JF. VA Epilepsy Cooperative Study Group, a method of quantification for the evaluation of antiepileptic drug therapy. Neurology. 1983;33(Suppl. 1):26–37
  24. Devinsky O. Outcome research in neurology: incorporating health-related quality of life. Ann. Neurol. 1995;37:141–142
  25. Dodson WE. Quality of life measurements in children with epilepsy. In:  Trimble MR,  Dodson WE editor. Epilepsy and Quality of Life. New York: Raven; 1994;p. 217–226
  26. Dodson WE. Principles of antiepileptic drug therapy. In: 4th Ed..  Shinnar S,  Amir N,  Branski D editor. Childhood Seizures. Pediatric and Adolescent Medicine. Vol. 6:Basel: Karger; 1995;p. 78–92
  27. Dulac O, Bulteau C. Quality of life of children with epilepsy. In:  Chadwick DW,  Baker GA,  Jacoby A editor. Quality of Life and Quality of Care in Epilepsy: Update 1993. London: Royal Society of Medicine Services; 1993;p. 40–49
  28. Duncan JS, Sander JWAS. The Chalfont Seizure severity scale. J. Neurol. Neurosurg. Psychiatry. 1991;54:873–876
  29. Engel J. Seizures and Epilepsy. In: Philadelphia: F.A. Davis Company; 1989;p. 380–409
  30. Farell K. Management of chronic epilepsy in children. In:  Trimble MR editors. Chronic Epilepsy, Its Prognosis and Management. Chichester: John Wiley and Sons; 1989;p. 151–164
  31. Feinstein AR. Principles and practice of clinimetrics in epilepsy. In:  Meinardi H,  Cramer JA,  Baker GA,  Martins da Silva A editor. Quantitative Assessment in Epilepsy Care. New York: Plenum; 1993;p. 1–10
  32. Fletcher AE, Gore SM, Jones DR, Fitzpatrick R, Spiegelhalter DJ, Cox DR. Quality of life measures in health care. II: design, analysis, and interpretation. B.M. 1992;305:1145–1148
  33. Freeman JM. A clinical approach to the child with seizures and epilepsy. Epilepsia. 1987;28(Suppl. 1):S103–S109
  34. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272:619–626
  35. Guyatt GH, Cook DJ. Health status, quality of life, and the individual. JAMA. 1994;272:630–631
  36. Guyatt GH, Jaeschke R. Measurements in clinical trials: choosing the appropriate approach. In:  Spilker B editors. Quality of Life in Clinical Trials. New York: Raven; 1990;p. 37–45
  37. Hauser WA. The distribution of mild and severe forms of epilepsy. In:  Trimble MR,  Dodson WE editor. Epilepsy and Quality of Life. New York: Raven; 1994;p. 249–258
  38. Heller AJ, Chesterman P, Elwes RDC, et al.  Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. JNNP. 1995;58:44–50
  39. Hermann BP. Quality of life in epilepsy. J. Epilepsy. 1992;5:153–165
  40. Hoare P, Russel M. The quality of life of children with chronic epilepsy and their families: preliminary findings with a new assessment measure. Dev. Med. Child. Neurol. 1995;37:689–696
  41. Huttenlocher PR, Hapke RJ. A follow-up study of intractable seizures in childhood. Ann. Neurol. 1990;28:699–705
  42. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In:  Macleod CM editors. Evaluation of Chemotherapeutic Agents. New York: Colombia University Press; 1949;p. 191–205
  43. Kernberg PF, Clarkin AJ, Greenblatt E, Cohen J. The Cornell interview of peers and friends: development and validation. J. Am. Acad. Child Adolesc. Psychiatry. 1992;31:483–489
  44. Koopman HM. De Kijk van Kinderen. In: 4th Ed.. Dissertation, with summary in English. Amsterdam: Thesis Publishers; 1993;
  45. Lammers MW, Hekster YA, Keyser A, et al.  Epilepsy treatment in The Netherlands. Comparison of matched groups of two medical centres. Acta Neurol. Scand. 1994;89:415–420
  46. Lammers MW, Meinardi H. On the reporting of adverse drug events. In:  Meinardi H,  Cramer JA,  Baker GA,  Martins da Silva A editor. Quantitative Assessment in Epilepsy Care. New York: Plenum; 1993;p. 117–122
  47. Levy SR. Epileptic syndromes and seizure types in children. Semin. Neurol. 1990;10:380–388
  48. Mattson RH. Selection of drugs for the treatment of epilepsy. Semin. Neurol. 1990;10:406–413
  49. Mattson RH. Drug treatment of uncontrolled seizures. Epilepsy Res. 1992;(Suppl. 5):29–35
  50. Mattson RH, Cramer JA. Quantitative assessment of adverse drug effects. In:  Meinardi H,  Cramer JA,  Baker GA,  Martins da Silva A editor. Quantitative Assessment in Epilepsy Care. New York: Plenum; 1993;p. 123–135
  51. Mattson RH, Cramer JA, Collins JF, et al.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N. Engl. J. Med. 1985;313:145–151
  52. Meador KJ. Research use of the new quality of life in epilepsy inventory. Epilepsia. 1993;34(Suppl. 4):S34–S38
  53. Meador KJ, Loring DW, Huh K, Gallagher BB, King DW. Comparative cognitive effects of anticonvulsants. Neurology. 1990;40:391–394
  54. Newson E. Parents as a resource in diagnosis and assessment. In:  Oppe TE,  Woodford FP editor. Early Management of Handicapping Disorders. Amsterdam: Associated Scientific Publishers; 1976;p. 105–117
  55. O'Donohoe NV. What should the child with epilepsy be allowed to do?. Arch. Dis. Childh. 1983;58:934–937
  56. Patrick DL, Deyo RA. Generic and disease specific measures in assessing health status and quality of life. Med. Care. 1989;27:S217–S232 (Suppl.)
  57. Perrine KR. A new quality of life inventory for epilepsy patients: interim results. Epilepsia. 1993;34(Suppl. 4):S28–S33
  58. Reynolds EH, Shorvon SD. Monotherapy or polytherapy for epilepsy?. Epilepsia. 1981;22:1–10
  59. Rosenbaum P, Cadman D, Kirpalani H. Pediatrics: Assessing Quality of Life. In:  Spilker B editors. Quality of Life Assessments in Clinical Trials. New York: Raven; 1990;p. 205–215
  60. Sander JWAS. Some aspects of prognosis in the epilepsies: a review. Epilepsia. 1993;34:1007–1016
  61. Scambler G. Coping with epilepsy. In: 4th Ed..  Laidlaw J,  Richens A,  Chadwick DW editor. A Textbook of Epilepsy. Edinburgh: Churchill Livingstone; 1993;p. 733–746
  62. Scambler S. Epilepsy and quality of life research. J. Roy. Soc. Med. 1993;86:449–450
  63. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In:  Spilker B editors. Quality of Life Assessments in Clinical Trials. New York: Raven; 1990;p. 11–25
  64. Schmidt D. Diagnostic and therapeutic management of intractable epilepsy. In:  Schmidt D,  Morselli PL editor. Intractable Epilepsy. New York: Raven; 1986;p. 237–257
  65. Seidenberg M, Beck N, Geisser M, et al.  Academic achievement of children with epilepsy. Epilepsia. 1986;27:753–759
  66. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient?. Br. J. Cancer. 1988;57:109–112
  67. Smith DF. Review of quality of life. In:  Chadwick DW,  Baker GA,  Jacoby A editor. Quality of Life and Quality of Care in Epilepsy: Update 1993. London: Royal Society of Medicine Services; 1993;p. 5–13
  68. Smith DF, Chadwick DW, Baker GA, Davis G, Dewey M. Seizure severity and the quality of life. Epilepsia. 1993;34(Suppl. 5):S31–S35
  69. Spilker B. Introduction. In:  Spilker B editors. Quality of Life Assessments in Clinical Trials. New York: Raven; 1990;p. 3–9
  70. Verity CM, Hosking G, Easter DJ  The Paediatric EPITEG Collaborative Group. a multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. Dev. Med. Child. Neurol. 1995;37:97–108
  71. Vickrey BG. A procedure for developing a quality-of-life measure for epilepsy surgery patients. Epilepsia. 1993;34(Suppl. 4):S22–S27
  72. Vickrey BG, Hays RD, Engel J, et al.  Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann. Neurol. 1995;37:158–166
  73. Wallace SJ. Seizures in children. In: 4th Ed..  Laidlaw J,  Richens A,  Chadwick DW editor. A Textbook of Epilepsy. Edinburgh: Churchill Livingstone; 1993;p. 77–164
  74. Wijsman DJP, Hekster YA, Keyser A, Renier WO, Meinardi H. Clinimetrics and epilepsy care. Pharm. Weekbl. Sci. 1991;13:182–188
  75. Wijsman DJP, Lammers MW, Hekster YA, et al.  Epilepsy treatment in The Netherlands. Comparison of two medical centres. Acta Neurol. Scand. 1993;87:438–442
  76. Willmore LJ. Summary of applications of quality of life. In:  Chadwick DW,  Baker GA,  Jacoby J editor. Quality of Life and Quality of Care in Epilepsy: Update 1993. London: Royal Society of Medicine Services; 1993;p. 97–100
  77. World Health Organization . In: 4th Ed.. International Classification of Impairments, Disabilities and Handicaps. A Manual of Classification Relating to the Consequences of Disease. Geneva: World Health Organization; 1980;
  78. Carpay JA, Arts WMA, Vermeulen J, Stroink H, Brouwer OF, Peters ACB, et al. Parent-completed scales for measuring seizure severity and severity of side-effects of antiepileptic drugs in childhood epilepsy: development and psychometric analysis. Epilepsy Res. 1996;24:173–181 1996

PII: 0920-1211(96)00013-7

Epilepsy Research
Volume 24, Issue 3 , Pages 127-136 , July 1996

Article Tools